In the U.S., 333 million COVID vaccine doses had been administered as of July 9. This includes: 135 million doses of Moderna’s vaccine, 184 million doses of Pfizer and 13 million doses of the Johnson & Johnson (J&J) COVID vaccine.
Of the 10,991 deaths reported as of July 9, 22% occurred within 48 hours of vaccination, 15% occurred within 24 hours and 37% occurred in people who became ill within 48 hours of being vaccinated.
This week’s data for 12- to 17-year-olds show:
14,003 total adverse events, including 866 rated as serious and 14 reported deaths. Two of the nine deaths were suicides.
The most recent reported death includes a 13-year-old boy (VAERS I.D. 1431289) with a previous history of COVID who suffered cardiac arrest and died 17 days after vaccination with Pfizer.
Other reports include two 13-year-old boys (VAERS I.D. 1406840 and 1429457) who died two days after receiving a Pfizer vaccine, three 15-year-olds (VAERS I.D. 1187918, 1382906 and 1242573), three 16-year-olds (VAERS I.D. 1420630, 1225942 and 1386841) and three 17-year-olds (VAERS I.D. 1199455, 1388042 and 1420762).
2,040 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases.
attributed to Pfizer’s vaccine, 1.1% to Moderna and 0.2% (or four cases) to J&J.
377 reports of myocarditis and pericarditis (heart inflammation) with 373 attributed to Pfizer’s vaccine.
65 reports of blood clotting disorders, with 64 attributed to Pfizer and 1 attributed to Moderna.
This week’s total VAERS data, from Dec. 14, 2020 to July 9, 2021, for all age groups combined show:
23% of deaths were related to cardiac disorders.
50% of those who died were male, 45% were female and the remaining death reports did not include gender of the deceased.
The average age of death was 75.
As of July 9, 2,857 pregnant women reported adverse events related to COVID vaccines, including 1072 reports of miscarriage or premature birth.
Of the 5,049 cases of Bell’s Palsy reported, 63% were attributed to Pfizer vaccinations, 35% to Moderna vaccine and 5% to J&J.
445 reports of Guillain-Barré Syndrome, with 51% of cases attributed to Pfizer, 37% to Moderna and 17% to J&J.
127,421 reports of anaphylaxis with 48% of cases attributed to Pfizer’s vaccine, 45% to Moderna and 7% to J&J.
9,471 reports of blood clotting disorders. Of those, 4,998 reports were attributed to Pfizer, 2,845 reports to Moderna and 1,582 reports to J&J.
1,991 cases of myocarditis and pericarditis with 1,336 cases attributed to Pfizer, 599 cases to Moderna and 52 cases to J&J’s COVID vaccine.
Experts warn of ‘huge risk’ as Moderna launches COVID vaccine trials for pregnant women
Moderna will study its COVID vaccine in pregnant women, according to a posting on ClinicalTrials.gov. The observational study, expected to begin July 22, will enroll about 1,000 females over age 18 who will be studied over a 21-month period.
Women who received a Moderna vaccine during the 28 days prior to their last menstrual period, or at any time during pregnancy, are eligible.
The brief summary of the trial states the main goal is “to evaluate the outcomes of pregnancy in females exposed to the Moderna COVID-19 vaccine (mRNA-1273) during pregnancy.”
Currently, the CDC says pregnant women can get a COVID vaccine. But the agency also acknowledges there is limited data available about the safety of COVID vaccines for people who are pregnant.
Tell Schools/Universities No Vaccine Mandates for Children/Young Adults!
“Pregnant women are taking what may be a huge risk with the COVID vaccine,” said Jennifer Margulis, Ph.D., author of “Your Baby, Your Way.” Margulis said in an email to The Defender, there is no evidence COVID vaccines are safe, but ample evidence suggesting it is dangerous to expose pregnant women and unborn babies to drugs and interventions that can disrupt immunity.
Lyn Redwood, RN, MSN and president emerita of Children’s Health Defense, said it’s “bass-ackwards to release the vaccine to pregnant women before doing a clinical trial or proper animal studies.”
FDA added warning to J&J vaccine of ‘serious but rare’ autoimmune disorder
On July 13, the FDA added a new warning on J&J’s (Janssen) COVID vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination.
According to an FDA news release, GBS is a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness or, in the most severe cases, paralysis.
Based on an analysis of VAERS data, there have been 100 preliminary reports of GBS following vaccination with J&J’s vaccine. Of these reports, 95 were serious and required hospitalization. There was one reported death.
While the cause of GBS is not fully known, it often follows infection with a virus and has been linked to other vaccines. The FDA concluded the benefits of the vaccine outweigh any danger, but included the proviso in fact sheets about the drug for providers and patients.
The CDC’s Advisory Committee on Immunization Practices (ACIP) is expected to discuss the GBS cases during an upcoming meeting, the CDC said.
Coroner says vaccine not to blame for man’s death after Pfizer— wife not convinced
A healthcare worker who died four days after his second dose of Pfizer’s COVID vaccine was killed by heart disease, according to the Orange County, California coroner.
As The Defender reported this week, Tim Zook, an x-ray technologist at South Coast Global Medical Center in Santa Ana, was hospitalized Jan. 5 — just hours after being vaccinated. Zook’s wife, Rochelle, told the Orange County Register her husband’s health rapidly deteriorated after receiving his second dose of Pfizer’s vaccine. He died Jan. 9.
An autopsy report released Wednesday found Zook’s heart was severely enlarged, thicker than normal and dilated. “There is a focus of severe coronary artery disease,” according to the report, which also said Zook’s heart valves showed mild-to-moderate calcium deposits
https://childrenshealthdefense.org/defender/vaers-deaths-injuries-reported-cdc-covid-vaccines-moderna-pregnant-women/
